Terms: = Leukemia AND MAML2, MAM3, 84441, ENSG00000184384, MAM-3, MLL-MAML2, Q8IZL2, KIAA1819, DKFZp686N0150, MAM2 AND Diagnosis
3 results:
1. KMT2A-maml2 rearrangement emerged and regressed during neuroblastoma therapy without leukemia after 12.8-year follow-up.
Felix CA; Slater DJ; Davenport JW; Yu X; Gregory BD; Li MM; Rappaport EF; Cheung NV
Pediatr Blood Cancer; 2022 Jan; 69(1):e29344. PubMed ID: 34550633
[TBL] [Abstract] [Full Text] [Related]
2. Copy number alterations determined by single nucleotide polymorphism array testing in the clinical laboratory are indicative of gene fusions in pediatric cancer patients.
Busse TM; Roth JJ; Wilmoth D; Wainwright L; Tooke L; Biegel JA
Genes Chromosomes Cancer; 2017 Oct; 56(10):730-749. PubMed ID: 28597942
[TBL] [Abstract] [Full Text] [Related]
3. Homozygous inv(11)(q21q23) and MLL gene rearrangement in two patients with myeloid neoplasms.
Tang G; Lu X; Wang SA; Roney EK; Zhang L; Hu S; Lu G; Medeiros LJ; Patel A
Int J Clin Exp Pathol; 2014; 7(6):3196-201. PubMed ID: 25031740
[TBL] [Abstract] [Full Text] [Related]